Conversely, high baseline or increasing anti-PLA2R antibody levels are associated with nephrotic syndrome and progressive loss of kidney function, thereby encouraging prompt initiation of immunosuppressive therapy (58). This evidence concerns the gene PLA2R1 and nephrotic syndrome.